Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Fierce Biotech's top 10 most-read stories of 2024
Large-scale site shutdowns, workforce reductions and pipeline reorganizations dominate the list.
Gabrielle Masson
Dec 23, 2024 3:00am
Pyxis whittles pipeline down to one clinical asset
Dec 20, 2024 6:15am
Merck discontinues development of 2 late-stage cancer assets
Dec 16, 2024 5:39pm
iTeos drops one of 3 clinical assets from pipeline
Dec 12, 2024 3:10pm
Novartis 'took data to heart' before slimming pipeline by 40%
Nov 21, 2024 5:07am
CSL Behring shuts down California cell and gene therapy R&D site
Nov 18, 2024 8:35am
